MétaCan
Menu
Back to cohort

238. EFFICACY OF CONVENTIONAL IMMUNOSUPPRESSANTS IN STEROID-DEPENDENT OR REFRACTORY EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: STUDY ON A NEW CANADIAN PATIENT COHORT

2019· article· en· W2926469363 on OpenAlexaffabout
Irena Doubelt, Natalie Pulenzas, Simon Carette, Christian Pagnoux

Bibliographic record

VenueLara D. Veeken · 2019
Typearticle
Languageen
FieldMedicine
TopicEosinophilic Esophagitis
Canadian institutionsMount Sinai HospitalUniversity of Toronto
Fundersnot available
KeywordsMedicineGranulomatosis with polyangiitisEosinophilicRefractory (planetary science)CohortDermatologyChurg-strauss syndromeVasculitisInternal medicinePathologyDisease

Abstract

fetched live from OpenAlex

Background: Mepolizumab and rituximab have been shown to be effective in relapsing, refractory and/or steroid-dependent eosinophilic granulomatosis with polyangiitis (EGPA), though limited data exists for conventional immunosuppressants. We aimed to describe a new cohort of adults with EGPA and report on the disease control efficacy of conventional immunosuppressants. Methods: A retrospective analysis of an EGPA cohort from Toronto was conducted. Five-year relapse-free survival analyses were computed comparing ANCA status, sex and year of diagnosis. Patients with relapsing, refractory and/or steroid-dependent EGPA with similar entry criteria as the main mepolizumab trial or rituximab cohort, who were started on conventional immunosuppressant’s, were assessed for remission at 24- and 52-weeks after treatment initiation. Remission was defined as a Birmingham Vasculitis Activity Score of 0 and a prednisone dose of 4 mg, ⩽7.5 mg or any prednisone dose per day (defined as MEPO4, MEPO7.5 or RITUX, corresponding to the mepolizumab or rituximab study endpoints, respectively). Results: In this cohort of 110 patients with EGPA, 1, 2, and ⩾3 relapses occurred in 38 (34.6%), 10 (9.1%), and 4 patients (3.6%), respectively. Five-year relapse-free survival rates were 40.9% (95% CI 0.490-0.698) for all patients; 40% (95% CI 0.371-0.683) for ANCA-positive and 39.2% (95% CI 0.463-0.750) for ANCA-negative patients (p = 0.683); 53.7% (95% CI 0.549-0.820) for females and 30.4% (95% CI 0.327-0.632) for males (p = 0.030); 64.3% (95% CI 0.543-0.803) for those diagnosed in 2010, and 40.7% (95% CI 0.298-0.635) for those diagnosed >2010 (p = 0.013). Twenty-four patients met eligibility criteria of relapsing, refractory and/or steroid-dependent EGPA and used methotrexate (n = 15), azathioprine (n = 8), or leflunomide (n = 1). Remission rates achieved at 24-weeks in our study [vs the corresponding mepolizumab or rituximab trial rates] were 8.3% for MEPO4 [vs. 28.0%]; 41.6% in MEPO7.5 [vs. 45%] and 62.5% for RITUX [vs. 34%]; remission at 52-weeks was 16.7% for MEPO4 [vs. 19%], 45.8% for MEPO7.5 [vs. 24%] and 50.0% for RITUX [vs. 49%]. Conclusion: Though retrospective biases must be acknowledged, the rates of remission observed in our study using conventional immunosuppressant’s were substantial and should be kept in mind when interpreting results of recent and future studies on biologics in EGPA. Disclosures: CP reports receiving fees for serving on advisory boards from Chemocentryx, GlaxoSmithKline, Sanofi and Hoffman-LaRoche; he also reports lecture fees and research grant support from Hoffman-La Roche.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.033
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.256
Teacher spread0.243 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueLara D. VeekenSame topicEosinophilic EsophagitisFrench-language works237,207